openPR Logo
Press release

Biopharmaceutical Logistics Market: Increased Manufacturing of Products That Need Cold Chain Shipment to Bolster Demand

10-07-2020 10:44 AM CET | Health & Medicine

Press release from: Transparency Market Research

Biopharmaceutical Logistics Market: Increased Manufacturing

The global biopharmaceutical logistics market is competitive nature with a large number of players operating worldwide, states a new research report by Transparency Market Research. The competition among the leading players is expected to strengthen a bit throughout the forecast period.

Read Report Overview - https://www.transparencymarketresearch.com/biopharmaceutical-logistics-market.html

Some of the prominent players operating in the global biopharmaceutical logistics market are FedEx Corporation, DHL Express, United Parcel Service, AmerisourceBergen Corporation, and DB Schenker. These players are focusing on enhancing their services to consumers in order to retain their position in the global market. In addition, the rising adoption of innovations and technological developments are estimated to accelerate the growth of the global market and offer promising growth opportunities for the leading players.

The global market for biopharmaceutical logistics is anticipated to register a progressive 6.20% CAGR between 2016 and 2024. Furthermore, in 2015, the market was valued at US$70.9 bn and is expected to reach a value of US$120.7 bn by the end of 2024.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=23858

Europe and North America to Lead Global Biopharmaceutical Logistics Market

Among the key regional segments, North America and Europe are anticipated to witness high growth throughout the forecast period. The high growth of these regions can be attributed to the increasing number of imports and exports for biopharmaceuticals. In addition, these two regions are the first ones to offer advanced technologies for the enhancement of warehousing and transportation in the supply chain. The presence of leading players in these regions and the willingness to adopt technological developments are some of the other key factors that are anticipated to encourage the growth of the biopharmaceutical logistics market throughout the forecast period.

Request for Analysis of COVID-19 Impact on Biopharmaceutical Logistics Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=23858

On the basis of mode of transport, the global market for biopharmaceutical logistics has been classified into air shipping, sea shipping, rail shipping, and road shipping. Among these, the air shipping segment is anticipated to register a healthy growth in the forecast period. The high growth of this segment can be attributed to the fast delivery offered by air shipping. On the other hand, the limitations on the volume of transportation by air shipping, the growth opportunities for road shipping, sea shipping, and rail shipping have increased significantly.

Growing Need to Offer Safe and Fast Transportation to Drive Market

The rising demand among biotechnology and biopharmaceutical companies to enhance their services and supply chain and further minimize temperature excursions is one of the major factor estimated to encourage the growth of the overall market in the next few years. The advent of advanced refrigeration and packaging has encouraged several logistics organizations to ensure safe transportation of goods. The increased adoption of technologies is estimated to generate promising growth opportunities for the global biopharmaceutical logistics market throughout the forecast period.

Buy Biopharmaceutical Logistics Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=23858<ype=S

On the other hand, the high cost of transportation of high-temperature and sensitive biopharmaceuticals is estimated to restrict the growth of the global biopharmaceutical logistics market in the next few years. Nonetheless, the rising production of drugs and targeted therapies is likely to offer potential growth opportunities for the players operating in the market.

More Trending Reports by Transparency Market Research –

Drug Discovery Informatics Market: https://www.biospace.com/article/drug-discovery-informatics-market-discovery-informatics-segment-dominated-the-market-/

Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopharmaceutical Logistics Market: Increased Manufacturing of Products That Need Cold Chain Shipment to Bolster Demand here

News-ID: 2151091 • Views:

More Releases from Transparency Market Research

Wireless Sensors Market to be Worth USD 80.6 Bn by 2036 - By Sensor Type / By Connectivity / By Application | U.S. • Japan • U.K. • Brazil
Wireless Sensors Market to be Worth USD 80.6 Bn by 2036 - By Sensor Type / By Co …
The global wireless sensors market is witnessing strong growth momentum, driven by rising digital transformation across industrial, infrastructure, healthcare, and smart city ecosystems. According to industry analysis, the wireless sensors market was valued at US$ 17.4 billion in 2025 and is projected to reach US$ 80.6 billion by 2036, expanding at a robust CAGR of 14.7% during the forecast period from 2026 to 2036. Access an overview of significant conclusions from
Skin Care Market to be Worth USD 318.1 Bn by 2036 - By Type / By Skin Type / By Distribution Channel | U.S. • Japan • Brazil • U.K.
Skin Care Market to be Worth USD 318.1 Bn by 2036 - By Type / By Skin Type / By …
The global skin care market continues to demonstrate steady growth, reflecting the increasing integration of skincare into daily health and wellness routines. The market was valued at US$ 195.8 billion in 2025 and is projected to reach US$ 318.1 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.5% from 2026 to 2036. Review critical insights and findings from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=340 The industry growth is
Healthcare Contract Research Outsourcing Market Outlook 2036: Market to Reach US$ 132.7 Billion at 7.2% CAGR Driven by Clinical Trial Complexity and Rising R&D Investments
Healthcare Contract Research Outsourcing Market Outlook 2036: Market to Reach US …
The global Healthcare Contract Research Outsourcing Market was valued at US$ 61.6 Bn in 2025 and is projected to reach US$ 132.7 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 7.2% from 2026 to 2036. The market's steady expansion reflects the growing reliance of pharmaceutical, biotechnology, and medical device companies on Contract Research Organizations (CROs) to optimize development costs and accelerate time-to-market. In 2025, North America accounted
Cervical Cancer Diagnostic Tests Market Outlook 2036: Global Industry to Reach US$ 9.6 Billion by 2036 Driven by HPV Testing, Government Screening Programs, and Molecular Diagnostic Innovations
Cervical Cancer Diagnostic Tests Market Outlook 2036: Global Industry to Reach U …
The global cervical cancer diagnostic tests market is on a steady growth trajectory, reflecting the rising global focus on women's health, preventive oncology, and early disease detection. Valued at US$ 5.4 Bn in 2025, the market is projected to reach US$ 9.6 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. Cervical cancer remains one of the most common cancers affecting women worldwide,

All 5 Releases


More Releases for Biopharmaceutical

Biopharmaceutical third-party logistics Market
Biopharmaceutical Third-Party Logistics Market to reach over USD 176.28 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopharmaceutical Third-Party Logistics Market Size, Share & Trends Analysis Report By Supply Chain (Cold Chain, Non-cold Chain), By Service Type (Transportation, Warehousing & Storage), Region, Market Outlook And Industry Analysis 2031" The global Biopharmaceutical third-party logistics market
Biopharmaceutical Fermentation Market Fueling Biopharmaceutical Innovation: The …
Biopharmaceutical Fermentation Market Worth USD 14.91billion by the year 2030- Exclusive Report by InsightAce Analytic The newly published report titled "Global Biopharmaceutical Fermentation Market (By Product (Upstream And Downstream Processes), Application (Antibiotics, Recombinant Proteins, Monoclonal Antibodies, Probiotics, And Others), End-User (Biopharmaceutical Industries, Contract Research Organizations, Food Industries, Academic Research Institutes, And Others))- Trends, Industry Competition Analysis, Covid-19 Analysis, Revenue (US$ Billions) And Forecast Till 2030." of InsightAce Analytic Pvt. Ltd.
Biopharmaceutical Cold Chain Transport Market Temperature-controlled Transport f …
Biopharmaceutical Cold Chain Transport Market 2023 Forecast: Unveiling Opportunities and Growth Biopharmaceutical Cold Chain Transport Market research report helps to recognize the market challenges and opportunities. Global Biopharmaceutical Cold Chain Transport Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of
Biopharmaceutical Transport Market Transport Se rvices for Biopharmaceutical Pro …
Biopharmaceutical Transport Market 2023 Forecast: Unveiling Opportunities and Growth Biopharmaceutical Transport Market research report helps to recognize the market challenges and opportunities. Global Biopharmaceutical Transport Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of every area including the volume of
Biopharmaceutical Market Industry Analysis - Biopharmaceutical Market Size Drive …
Acumen Research and Consulting has recently published a research report on the Biopharmaceutical Market for the forecast period of 2022 - 2030, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the Biopharmaceutical Market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through 2030. The research study on the Biopharmaceutical Market analyzes key drivers upholding product sales
Biopharmaceutical CMO and CRO Market
The Biopharmaceutical CMO and CRO Market crossed US$ 32.25 billion in 2022 and is expected to hit US$ 54.13 billion by 2030, recording a CAGR of 6.5% during the forecast period Pharmaceutical and biotech companies focus on R&D activities to innovate new molecules and therapeutic platforms to deal with chronic diseases and rare ailments; they also extensively invest in R&D activities to develop various therapeutic applications with strong medical and commercial